Nintedanib 150mg capsules
NHS hospitals in England used £129,001,287 of indicative cost of Nintedanib 150mg capsules in the 12 months to April 2026, about 0.5% of all hospital medicines spend. That is up 18.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Nintedanib 150mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Nintedanib 150mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £25,473,734 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £9,715,843 |
| Manchester University Nhs Ft | £9,017,488 |
| Royal Papworth Hospital Nhs Ft | £8,617,312 |
| Leeds Teaching Hpls Nhs Trust | £7,797,025 |
| Royal Devon & Exeter Nhs Foundation Trst | £5,952,097 |
| Oxford University Hospitals Nhs Ft | £5,355,848 |
| Univ Hpl B/Ham Nhs Foundation Trust | £5,339,642 |
| University Hpls Of Leicester Nhs Trust | £5,005,684 |
| North Bristol Nhs Trust | £4,932,475 |
The primary-care picture
Nintedanib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Nintedanib medicine page.